| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acaa290e64acdba63d240a4361e444ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e83c6d0c99b47cca934fb37f183cf1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_427c2dca2ab623be34fd2273a9e67387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc25bc88bf881047128e42f407f9b44e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5251fb2372393e6766f5e11498d4d59e |
| publicationDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011247465-A1 |
| titleOfInvention |
Detection and modulation of Slit and Roundabount (Robo) mediated lymph vessel formation and uses thereof |
| abstract |
The invention provides a method for preventing or treating a disorder mediated by a Slit protein, which comprises administering to a subject a therapeutically effective amount of an agent for modulating or preventing interactions between the Slit protein and a Robo protein, wherein the disorder involves lymph vessel formation. The invention further discloses a composition for preventing or treating a disorder mediated by the Slit protein and a method for prognosing or diagnosing a disease or disorder mediated by the Slit protein. |
| priorityDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |